# US 2002/0165464 A1 · Assessment of organs for transplant, xenotransplant, and predicting time of death

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0165464 A1
- Document ID: US20020165464A1
- Status: Published application
- Kind: A1
- Application number: 09/848,242
- Filed: 2001-05-03
- Published: 2002-11-07
- Earliest claimed: 2001-05-03
- Assignees: The Nutrition Solutions Corporation
- Inventors: Michaeal G. Singer
- Web page: https://patentgrep.com/patent/US20020165464A1

## CPC

- A61B 5/4869: {Determining body composition}
- A61B 5/053: Measuring electrical impedance or conductance of a portion of the body
- A61B 5/413: {Monitoring transplanted tissue or organ, e.g. for possible rejection reactions after a transplant}
- G01N 33/48707: {by electrical means (G01N33/49, G01N33/493 take precedence)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method and system for utilization of bioelectrical impedance analysis (BIA) in a biological model for body composition analysis (BCA) to provide an objective assessment of an organ's and/or biological entity's volume and distribution of fluids and tissue as well as the electrical health of cells and membranes. A method for determining illness of a biological entity, progression to death of the biological entity, and/or timing of death of the biological entity, and a method of organ vitality assessment for transplantation of the organ being assessed.

## Claims

### Claim 1

A method for determining illness of a biological entity, progression to death of said biological entity, and/or timing of death of said biological entity, comprising the steps of:
taking whole body measurements of resistance, reactance, phase angle, extracellular water volume, and intracellular water volume at predetermined intervals of time;
recording said whole body measurements;
comparing initial values of said whole body measurements to normal values of said whole body measurements and to serially measured values of said whole body measurements; and
determining from said comparison step hallmarks of said illness of said biological entity, said progression to said death of said biological entity, and/or said death of said biological entity.

### Claim 2 (depends on 1)

A method according to claim 1, wherein:
said hallmarks include an uncorrectable loss of cell mass and membrane capacity as evidenced by a reduction in said reactance and phase angle.

### Claim 3 (depends on 1)

A method according to claim 1, wherein:
said hallmarks include an uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume.

### Claim 4 (depends on 2)

A method according to claim 2, wherein:
said hallmarks include an uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume.

### Claim 5 (depends on 2)

A method according to claim 2, wherein:
when said uncorrectable loss of cell mass and membrane capacity remains uncorrectable, these are hallmarks of said progression to said death of said biological entity.

### Claim 6 (depends on 4)

A method according to claim 4, wherein:
when said uncorrectable loss of cell mass and membrane capacity remains uncorrectable, these are hallmarks of said progression to said death of said biological entity.

### Claim 7 (depends on 3)

A method according to claim 3, wherein:
when said uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume remains uncorrectable, these are hallmarks of said progression to said death of said biological entity.

### Claim 8 (depends on 4)

A method according to claim 4, wherein:
when said uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume remains uncorrectable, these are hallmarks of said progression to said death of said biological entity.

### Claim 9 (depends on 6)

A method according to claim 6, wherein:
when said uncorrectable and increasing disparity of said extracellular water volume being greater than said intracellular water volume remains uncorrectable, these are hallmarks of said progression to said death of said biological entity.

### Claim 10 (depends on 1)

A method according to claim 1, wherein:
values of said phase angle less than four degrees denote serious illness of said biological entity, and
values of said phase angle less than two degrees denote imminent death of said biological entity.

### Claim 11 (depends on 2)

A method according to claim 2, wherein:
values of said phase angle less than four degrees denote serious illness of said biological entity; and
values of said phase angle less than two degrees denote imminent death of said biological entity.

### Claim 12 (depends on 3)

A method according to claim 3, wherein:
values of said phase angle less than four degrees denote serious illness of said biological entity; and
values of said phase angle less than two degrees denote imminent death of said biological entity.

### Claim 13 (depends on 4)

A method according to claim 4, wherein:
values of said phase angle less than four degrees denote serious illness of said biological entity; and
values of said phase angle less than two degrees denote imminent death of said biological entity.

### Claim 14 (depends on 5)

A method according to claim 5, wherein:
values of said phase angle less than four degrees denote serious illness of said biological entity; and
values of said phase angle less than two degrees denote imminent death of said biological entity.

### Claim 15 (depends on 1)

A method according to claim 1, wherein:
said whole body measurements of said resistance, said reactance, said phase angle, said extracellular water volume, and said intracellular water volume are taken every other day.

### Claim 16 (depends on 2)

A method according to claim 2, wherein:
said whole body measurements of said resistance, said reactance, said phase angle, said extracellular water volume, and said intracellular water volume are taken every other day.

### Claim 17 (depends on 3)

A method according to claim 3, wherein:
said whole body measurements of said resistance, said reactance, said phase angle, said extracellular water volume, and said intracellular water volume are taken every other day.

### Claim 18

A method of organ vitality assessment for transplantation of said organ being assessed, comprising the steps of:
placing signal introduction electrodes on opposite lateral peripheral borders of said organ upon harvesting of said organ;
placing signal detection electrodes at superior and inferior borders of said organ for a first part of an initial measurement upon said harvesting of said organ;
measuring and recording first values of resistance and reactance of said organ in said initial measurement;
then placing said signal introduction electrodes on said superior and said inferior borders of said organ;
placing said signal detection electrodes on said opposite lateral borders of said organ;
measuring and recording second values of said resistance and said reactance of said organ; and
comparing said first and second values to normal values to determine if said organ is acceptable or not for said transplantation.

### Claim 19 (depends on 18)

A method according to claim 18, wherein:
if said organ is acceptable, then prior to implanting said organ, performing the following steps;
again placing said signal introduction electrodes on said opposite lateral peripheral borders of said organ;
again placing said signal detection electrodes at said superior and said inferior borders of said organ for a first part of an initial post-harvest/pre-implant measurement;
measuring and recording third values of resistance and reactance of said organ in said initial post-harvest/pre-implant measurement;
then placing said signal introduction electrodes on said superior and said inferior borders of said organ;
placing said signal detection electrodes on said opposite lateral borders of said organ;
measuring and recording fourth values of said resistance and said reactance of said organ; and
comparing said first and second values to said third and fourth values to determine if the values are within a predetermined acceptable range of agreement denoting no further loss of said organ vitality.

### Claim 20 (depends on 18)

A method according to claim 18, including:
harvesting said organ from a first species of biological entity; and
implanting said organ in a different species of biological entity.
